Monographie - Morphine tartrate - Stabilis 4.0

Siste oppdatering :
19/11/2024

Analgetika

Morphine tartrate

Injeksjon

Oppløsningsstabilitet

Stabilitet i blandinger

Faktorer som påvirker stabiliteten

Kompatibilitet

Administrasjonsmåte

Referanser

pdf

Kjemisk struktur

Handelsnavn

Handelsnavn

Handelsnavn er veiledende og sammensetning av hjelpestoffer kan være forskjellig avhengig av land og produsent

Morphine tartrate

Australia

Referanser

Injeksjon

Referanser : Morphine tartrate

	Type	publikasjon
519	Journal	Poggi GL. Compatibility of morphine tartrate admixtures in polypropylene syringes. Aust J Hosp Pharm 1991 ; 21: 316.
920	Journal	Targett PL, Keefe PA, Merridew CG. Stability of two concentrations of morphine tartrate in 10 mL polypropylene syringes. Aust J Hosp Pharm 1997 ; 27: 452-454.
980	Journal	Ambados F. Compatibility of morphine and ketamine for subcutaneous infusion. Aust J Hosp Pharm 1995 ; 25: 352.
1864	Journal	Lau MH, Hackman C, Morgan DJ. Compatibility of ketamine and morphin injections. Pain 1998 ; 75: 389-390.
2083	Journal	La Forgia SP, Sharley NA, Burgess NG, Doecke CJ. Stability and compatibility of morphine, midazolam and bupivacaine combinaisons for iontravenous infusion. J Pharm Pract and Res 2002 ; 32: 65-68.
3474	Labratorium	Fluorouracil - Summary of Product Characteristics Accord Healthcare Limited 2009
3504	Labratorium	Parecoxib (Dynastat®) - Summary of Product Characteristics Pfizer 2012
3644	Labratorium	Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010
3675	Labratorium	Thiopental sodium - Summary of Product Characteristics Archimedes Pharma UK Ltd 2015
3838	Labratorium	Magnesium Sulphate - Summary of Product Characteristics Martindale Pharmaceuticals Ltd 2007
3934	Labratorium	Eptifibatide (Integrilin®) - Résumé des caractéristiques du produit GlaxoSmithKline Laboratoire 2016

Mentions Légales